{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:18:06Z","timestamp":1791321486623,"version":"4.3.1"},"reference-count":26,"publisher":"Cambridge University Press (CUP)","issue":"4","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Infect. Control Hosp. Epidemiol."],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"S0899823X25103942_as1\">\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To understand current practices for screening, implementing and clearing contact precautions (CP) for multidrug-resistant organisms (MDRO).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0899823X25103942_as2\">\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>A survey of US-based SHEA Research Network (SRN) members and Community Healthcare Epidemiologists and Stewards (CHES).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0899823X25103942_as3\">\n                    <jats:title>Participants:<\/jats:title>\n                    <jats:p>The SRN is a consortium of healthcare facilities collaborating on multicenter research projects. CHES is an SRN-affiliated group of community hospital epidemiologists.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0899823X25103942_as4\">\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      A Research Electronic Data Capture (REDCap) survey was administered between January 7, 2025 and February 25, 2025. Frequencies and proportions were calculated in REDCap and Microsoft Excel. Fisher\u2019s exact and\n                      <jats:italic>\u03c7<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      tests were calculated in\n                      <jats:italic>R<\/jats:italic>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0899823X25103942_as5\">\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Of 134 facilities, 60 (45%) responded; 4 answered only demographic questions and were excluded from analysis. Most facilities (70%) performed active surveillance for \u22651 MDRO, but only 16% employed preemptive CP. All respondents reported using CP for \u22651 MDRO. CP were employed more often for infection than colonization. Clearance protocols to discontinue CP were common for MRSA (97%),\n                      <jats:italic>C. difficile<\/jats:italic>\n                      (95%), and vancomycin-resistant enterococci (82%), but uncommon for Gram-negatives. Training and adherence of frontline staff (70%), unavailability of private rooms (41%), and lack of evidence-based strategies to eradicate reservoirs (34%) were the top 3 identified barriers to MDRO infection control and prevention.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S0899823X25103942_as6\">\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Infection control practices varied by infection, colonization, specific MDRO, and time to clearance. Variation may indicate need for more data on transmission risk by disease state, organism, and time. Evidence-based strategies are needed to guide MDRO prioritization and CP duration and clearance policies. Guidance should acknowledge limitations in adherence, availability of private rooms, and persistent environmental reservoirs as major barriers to MDRO containment identified in this survey.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1017\/ice.2025.10394","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T08:07:14Z","timestamp":1771402034000},"page":"386-393","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":1,"title":["Current infection control practices for multidrug-resistant organisms (MDRO): a survey of the Society for Healthcare Epidemiology of America (SHEA) research network and affiliated US-based hospitals"],"prefix":"10.1017","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1548-7202","authenticated-orcid":false,"given":"K.C.","family":"Coffey","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/002pd6e78","id-type":"ROR","asserted-by":"publisher"}],"name":"Massachusetts General Hospital and Harvard Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4569-0454","authenticated-orcid":false,"given":"Trudy","family":"Grossman","sequence":"additional","affiliation":[{"name":"Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4429-7750","authenticated-orcid":false,"given":"David B.","family":"Banach","sequence":"additional","affiliation":[{"name":"University of Connecticut School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony D.","family":"Harris","sequence":"additional","affiliation":[{"name":"University of Maryland School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1444-9939","authenticated-orcid":false,"given":"David C.","family":"Hooper","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/002pd6e78","id-type":"ROR","asserted-by":"publisher"}],"name":"Massachusetts General Hospital and Harvard Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6748-3447","authenticated-orcid":false,"given":"Susan S.","family":"Huang","sequence":"additional","affiliation":[{"name":"University of California Irvine School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica S.","family":"Shenoy","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/002pd6e78","id-type":"ROR","asserted-by":"publisher"}],"name":"Massachusetts General Hospital and Harvard Medical School"},{"name":"Mass General Brigham Inc."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"S0899823X25103942_ref23","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jhin.2020.12.012","article-title":"Risk factors for transmission of carbapenem-resistant enterobacterales to healthcare personnel gloves and gowns in the USA","volume":"109","author":"Nguyen","year":"2021","journal-title":"J Hosp Infect"},{"key":"S0899823X25103942_ref14","unstructured":"14. Antimicrobial Resistance Threats in the United States. 2021-2022 | Antimicrobial Resistance | CDC. https:\/\/www.cdc.gov\/antimicrobial-resistance\/data-research\/threats\/update-2022.html. Accessed May 29, 2025."},{"key":"S0899823X25103942_ref12","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2016.242"},{"key":"S0899823X25103942_ref2","unstructured":"2. CDC. The biggest antibiotic-resistant threats in the U.S. Centers for Disease Control and Prevention. 2022. https:\/\/www.cdc.gov\/antimicrobial-resistance\/data-research\/threats\/?CDC_AAref_Val=https:\/\/www.cdc.gov\/drugresistance\/biggest-threats.html.Accessed April 12, 2024."},{"key":"S0899823X25103942_ref21","doi-asserted-by":"publisher","DOI":"10.1086\/676861"},{"key":"S0899823X25103942_ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208"},{"key":"S0899823X25103942_ref18","doi-asserted-by":"publisher","DOI":"10.1017\/ash.2024.271"},{"key":"S0899823X25103942_ref5","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-019-0479-5"},{"key":"S0899823X25103942_ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2015.08.019"},{"key":"S0899823X25103942_ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"S0899823X25103942_ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2020.12.007"},{"key":"S0899823X25103942_ref26","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2023.102"},{"key":"S0899823X25103942_ref22","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2018.359"},{"key":"S0899823X25103942_ref19","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-177"},{"key":"S0899823X25103942_ref25","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaf365"},{"key":"S0899823X25103942_ref1","first-page":"3717","article-title":"Clinical significance of MDRO screening and infection risk factor analysis in the ICU","volume":"13","author":"Zhou","year":"2021","journal-title":"Am J Transl Res"},{"key":"S0899823X25103942_ref6","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2016.139"},{"key":"S0899823X25103942_ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2012.03.014"},{"key":"S0899823X25103942_ref24","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofae712"},{"key":"S0899823X25103942_ref8","unstructured":"8. SRN \u2013 SHEA Foundation. SRN Studies. https:\/\/shea-foundation.org\/research-network\/. Accessed October 15, 2025."},{"key":"S0899823X25103942_ref7","doi-asserted-by":"publisher","DOI":"10.1086\/668427"},{"key":"S0899823X25103942_ref13","unstructured":"13. AHA Hospital Statistics. https:\/\/guide.prod.iam.aha.org\/stats\/. Accessed April 7, 2024."},{"key":"S0899823X25103942_ref15","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaf695.1252"},{"key":"S0899823X25103942_ref3","unstructured":"3. Centers for Disease Control and Prevention (U.S.). Antibiotic Resistance Threats in the United States, 2019. Centers for Disease Control and Prevention (U.S.). 2019. https:\/\/10.15620\/cdc:82532."},{"key":"S0899823X25103942_ref11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0289163"},{"key":"S0899823X25103942_ref9","doi-asserted-by":"publisher","DOI":"10.1086\/675600"}],"container-title":["Infection Control &amp; Hospital Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0899823X25103942","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T03:06:15Z","timestamp":1776999975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0899823X25103942\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0899823X25103942"],"URL":"https:\/\/doi.org\/10.1017\/ice.2025.10394","relation":{},"ISSN":["0899-823X","1559-6834"],"issn-type":[{"value":"0899-823X","type":"print"},{"value":"1559-6834","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"assertion":[{"value":"\u00a9 The Author(s), 2026. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https:\/\/creativecommons.org\/licenses\/by\/4.0\/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}